Sign up Australia
Proactive Investors - Run By Investors For Investors

Eleven Biotherapeutics changes its name to Sesen Bio

The new name Sesen- which stands for an ancient symbol of the lotus flower- better defines the company's focus on oncology
Cancer in body
The company's shares are trading sharply higher in afternoon trade

Eleven Biotherapeutics has opted to change its name to Sesen Bio and its stock ticker to SESN, starting tomorrow.

The move comes less than two years after the late-stage clinical company acquired Viventia Bio in a bid to launch a targeted protein therapeutics oncology group.

The new name Sesen – which stands for an ancient symbol of the lotus flower – better defines the company’s ambition to dedicate itself to oncology and to cater to patients who suffer from devastating cancers.

The news cheered investors who sent Eleven Biotherapeutic’s shares up 22% to US$3.23 in afternoon trade.

View full EBIO profile View Profile

Eleven Biotherapeutics Timeline

Related Articles

Picture of Malaysian city
May 09 2018
The group’s ability to provide benefits to the retail sector was demonstrated in 2017.
Picture of facilities at Bauxite Hills
May 11 2018
The project is forecast to generate earnings before interest, tax, depreciation and amortisation (EBITDA) of $2.5 billion.
Enertopia Corp's partner GWT upbeat on potential of lithium recovery tests
October 26 2017
The feedstock used in the tests comes from the group's Clayton valley project in Nevada

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use